Soleno Therapeutics Inc financial data

Symbol
SLNO on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
100 Marine Parkway, Suite 400, Redwood City, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Capnia, Inc. (to 5/11/2017)
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.73K % +824%
Debt-to-equity 12.3 % -93.5%
Return On Equity -62 % +77.3%
Return On Assets -55.2 % +41.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 43.1M shares +41.4%
Common Stock, Shares, Outstanding 41M shares +165%
Entity Public Float 33.1M USD +324%
Common Stock, Value, Issued 41K USD +173%
Weighted Average Number of Shares Outstanding, Basic 41.9M shares +266%
Weighted Average Number of Shares Outstanding, Diluted 41.9M shares +266%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 65.8M USD +224%
General and Administrative Expense 72.7M USD +519%
Operating Income (Loss) -142M USD -331%
Nonoperating Income (Expense) 11.3M USD
Net Income (Loss) Attributable to Parent -131M USD -295%
Earnings Per Share, Basic -2.71 USD/shares +11.7%
Earnings Per Share, Diluted -2.71 USD/shares +11.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 48.4M USD -7.67%
Marketable Securities, Current 208M USD
Assets, Current 258M USD +381%
Property, Plant and Equipment, Net 196K USD +1207%
Operating Lease, Right-of-Use Asset 2.99M USD +531%
Intangible Assets, Net (Excluding Goodwill) 7.29M USD -21.1%
Other Assets, Noncurrent 83K USD -49.7%
Assets 297M USD +367%
Accounts Payable, Current 6.24M USD +94.1%
Employee-related Liabilities, Current 3.41M USD +128%
Liabilities, Current 15M USD -48.4%
Operating Lease, Liability, Noncurrent 2.58M USD +1106%
Liabilities 32M USD -20.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 895K USD
Retained Earnings (Accumulated Deficit) -396M USD -49.5%
Stockholders' Equity Attributable to Parent 265M USD +1040%
Liabilities and Equity 297M USD +367%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.5M USD -86.2%
Net Cash Provided by (Used in) Financing Activities 938K USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 41M shares +165%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -127M USD -1785%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 48.4M USD -7.67%
Deferred Tax Assets, Valuation Allowance 66M USD +15.7%
Deferred Tax Assets, Gross 67.9M USD +13.2%
Operating Lease, Liability 3.03M USD
Payments to Acquire Property, Plant, and Equipment 11K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -75.6M USD -596%
Lessee, Operating Lease, Liability, to be Paid 3.81M USD
Property, Plant and Equipment, Gross 101K USD 0%
Operating Lease, Liability, Current 448K USD +75%
Lessee, Operating Lease, Liability, to be Paid, Year Two 751K USD +425%
Lessee, Operating Lease, Liability, to be Paid, Year One 526K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 780K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 861K USD
Deferred Tax Assets, Operating Loss Carryforwards 51.5M USD +5.01%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 2.94M USD +51.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 942K USD
Operating Lease, Payments 64K USD -46.2%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 66M USD +15.7%
Share-based Payment Arrangement, Expense 72.1M USD +1445%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%